diethyl ((2S,2'S)-((2S,2'S)-2,2'-(((ethyne-1,2-diylbis(3,1-phenylene))bis(azanediyl))bis(carbonyl))bis(pyrrolidine-2,1-diyl))bis(4-methyl-1-oxopentane-2,1-diyl))dicarbamate

ID: ALA5173669

Chembl Id: CHEMBL5173669

PubChem CID: 168277631

Max Phase: Preclinical

Molecular Formula: C42H56N6O8

Molecular Weight: 772.94

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)Nc1cccc(C#Cc2cccc(NC(=O)[C@@H]3CCCN3C(=O)[C@H](CC(C)C)NC(=O)OCC)c2)c1

Standard InChI:  InChI=1S/C42H56N6O8/c1-7-55-41(53)45-33(23-27(3)4)39(51)47-21-11-17-35(47)37(49)43-31-15-9-13-29(25-31)19-20-30-14-10-16-32(26-30)44-38(50)36-18-12-22-48(36)40(52)34(24-28(5)6)46-42(54)56-8-2/h9-10,13-16,25-28,33-36H,7-8,11-12,17-18,21-24H2,1-6H3,(H,43,49)(H,44,50)(H,45,53)(H,46,54)/t33-,34-,35-,36-/m0/s1

Standard InChI Key:  JVEDBURJFTVMJP-ZYADHFCISA-N

Alternative Forms

  1. Parent:

    ALA5173669

    ---

Associated Targets(Human)

Huh-5-2 (386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hepatitis C virus (23859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 772.94Molecular Weight (Monoisotopic): 772.4160AlogP: 5.27#Rotatable Bonds: 14
Polar Surface Area: 175.48Molecular Species: NEUTRALHBA: 8HBD: 4
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 4#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.63CX Basic pKa: CX LogP: 5.43CX LogD: 5.43
Aromatic Rings: 2Heavy Atoms: 56QED Weighted: 0.19Np Likeness Score: -0.61

References

1. Abdallah M, Hamed MM, Frakolaki E, Katsamakas S, Vassilaki N, Bartenschlager R, Zoidis G, Hirsch AKH, Abdel-Halim M, Abadi AH..  (2022)  Redesigning of the cap conformation and symmetry of the diphenylethyne core to yield highly potent pan-genotypic NS5A inhibitors with high potency and high resistance barrier.,  229  [PMID:34959173] [10.1016/j.ejmech.2021.114034]

Source